Greil, R., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., . . . Sordillo, P. P. (2018). A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc(™)) in patients with locally advanced or metastatic cancer. Cancer Chemother Pharmacol.
Stile di citazione ChicagoGreil, Richard, Sigrun Greil-Ressler, Lukas Weiss, Charlotte Schönlieb, Teresa Magnes, Bianca Radl, Gordon T. Bolger, Brigitta Vcelar, e Peter P. Sordillo. "A Phase 1 Dose-escalation Study On the Safety, Tolerability and Activity of Liposomal Curcumin (Lipocurc(™)) in Patients With Locally Advanced or Metastatic Cancer." Cancer Chemother Pharmacol 2018.
Citazione MLAGreil, Richard, et al. "A Phase 1 Dose-escalation Study On the Safety, Tolerability and Activity of Liposomal Curcumin (Lipocurc(™)) in Patients With Locally Advanced or Metastatic Cancer." Cancer Chemother Pharmacol 2018.